Kedudukan dalam Saham
#28065
Gencurix Inc. provides diagnostic solutions in South Korea. Its products... Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Perubahan (1 tahun)
5.81%
Perdagangan Gencurix, Inc. (229000)
Harga 229000 dengan permodalan pasaran b
Modal pasaran bagi Gencurix, Inc.(229000)
Modal Pasaran: $28.30M
Sehingga August 2026, Gencurix, Inc. mempunyai modal pasaran sebanyak $28.30M. Ini menjadikan Gencurix, Inc. syarikat ke-28065th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Gencurix, Inc. dari 2017 hingga 2026
229000 berbanding dengan 5 teratas yang paling popular stocks
| Harga 229000 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+18,728,248.41%
|
|
|
|
|
$4.634T
|
+16,371,689.73%
|
|
|
|
|
$4.143T
|
+14,637,349.55%
|
|
|
|
|
$3.589T
|
+12,681,412.50%
|
|
|
|
|
$2.857T
|
+10,093,705.31%
|
